Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022 14 oktober 2022NewsHumanCOVID-19MedicinesMedicines for use outside the EU High-quality data to empower data-driven medicines regulation in the European Union 10 oktober 2022NewsHumanCorporateMedicines EMA Management Board: highlights of October 2022 meeting 7 oktober 2022NewsCorporate Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022 7 oktober 2022NewsVeterinaryMedicines Chair of the European Network of Paediatric Research at EMA re-elected 5 oktober 2022NewsMedicinesPaediatrics Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 oktober 2022News Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 september 2022NewsCorporate New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 september 2022NewsHumanMedicinesReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 september 2022NewsHumanPharmacovigilanceReferrals EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 september 2022NewsHumanAdvanced therapiesMedicines 1 … 35 36 37 38 39 Page 39 of 380 40 41 42 43 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022 14 oktober 2022NewsHumanCOVID-19MedicinesMedicines for use outside the EU
High-quality data to empower data-driven medicines regulation in the European Union 10 oktober 2022NewsHumanCorporateMedicines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022 7 oktober 2022NewsVeterinaryMedicines
Chair of the European Network of Paediatric Research at EMA re-elected 5 oktober 2022NewsMedicinesPaediatrics
Call for expression of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee 5 oktober 2022News
Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 september 2022NewsCorporate
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 september 2022NewsHumanMedicinesReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 september 2022NewsHumanPharmacovigilanceReferrals
EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 september 2022NewsHumanAdvanced therapiesMedicines